Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer’s Disease

Twelve derivatives <b>1a</b>–<b>1m</b> of the β-crinane-type alkaloid haemanthamine were developed. All the semisynthetic derivatives were studied for their inhibitory potential against both acetylcholinesterase and butyrylcholinesterase. In addition, glycogen synthase kinase...

ver descrição completa

Detalhes bibliográficos
Autores: Kohelová, Eliška, Peřinová, Rozálie, Maafi, Negar, Korábečný, Jan, Hulcová, Daniela, Maříková, Jana, Kučera, Tomáš, Martínez-González, Loreto, Hrabinová, Martina, Vorčáková, Katarina, Nováková, Lucie, De Simone, Angela, Havelek, Radim, Cahlíková, Lucie
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Recursos:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/180181
Acesso em linha:http://hdl.handle.net/10261/180181
Access Level:acceso abierto
Palavra-chave:Haemanthamine
Amaryllidaceae
Alzheimer’s disease
Acetylcholinesterase
Butyrylcholinesterase
Glycogen synthase kinase-3β inhibition
Docking studies
Descrição
Resumo:Twelve derivatives <b>1a</b>–<b>1m</b> of the β-crinane-type alkaloid haemanthamine were developed. All the semisynthetic derivatives were studied for their inhibitory potential against both acetylcholinesterase and butyrylcholinesterase. In addition, glycogen synthase kinase 3β (GSK-3β) inhibition potency was evaluated in the active derivatives. In order to reveal the availability of the drugs to the CNS, we elucidated the potential of selected derivatives to penetrate through the blood-brain barrier (BBB). Two compounds, namely 11-<i>O</i>-(2-methylbenzoyl)-haemanthamine (<b>1j</b>) and 11-<i>O</i>-(4-nitrobenzoyl)-haemanthamine (<b>1m</b>), revealed the most intriguing profile, both being acetylcholinesterase (<i>h</i>AChE) inhibitors on a micromolar scale, with GSK-3β inhibition properties, and predicted permeation through the BBB. In vitro data were further corroborated by detailed inspection of the compounds’ plausible binding modes in the active sites of <i>h</i>AChE and <i>h</i>BuChE, which led us to provide the structural determinants responsible for the activity towards these enzymes.